ClinicalTrials.gg
CompletedNCT00604487Updated Feb 22, 2016

Induction of Labor in Patients With Unfavorable Cervical Conditions

An interventional study of ARD (Atad Ripener Device) and AID (Atad double balloon Instillation Device) in Unfavorable Cervix for Induction of Labor, sponsored by Hillel Yaffe Medical Center. Completed at 1 site in Israel. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-02-22.

Sponsored by Hillel Yaffe Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Artificial ripening of the cervix and induction of labor remain as one of the therapeutic challenges in Obstetrics. The method widely used, the intravenous administration of Oxytocin, is associated with prolonged induction periods, a significant failure rate, and considerable patient discomfort. Therefore, over the years, a variety of locally applied pharmacological and physical ripening agents were evaluated. Currently, the commonly utilised local ripening agent is a Prostaglandin (PG) preparation. Although PG is being applied vaginally or extra-amniotically, systemic absorption of this agent is common, sometimes resulting in uterine hypertonicity, nausea and vomiting. In addition, both induction methods are associated with the initiation of uterine contractions, sometimes lasting for prolonged periods. Therefore a preferred induction method may be a mechanical one which will lead to cervical ripening without causing uterine contractions. Furthermore, there are additional potential advantages of mechanical methods compared to pharmacologic methods such as, ease of storage, low cost and less side effects. A folly catheter, inserted through the cervix, combined with continuous extra-amniotic NS instillation is being used for this purpose for many years. However this method although effective may cause uncomfortable traction of the balloon to the women's leg. Furthermore, dripping of saline through the cervix and vagina, occasionally occurs, may be annoying, and may be confused with rupture of membrane. We have recently introduced a newly developed balloon device (Atad Ripener Device), which was designed with one balloon located at the distal end of the device (the uterine balloon, U), while the other balloon is located 1.5 cm proximal to the first one (the cervicovaginal balloon, CV). Both balloons are expandable with Saline. The balloon inflated in the vagina provides the traction action and seals the cervix from saline leakage. Another balloon the AID (Atad double balloon Instillation Device) is identical to the ARD but has an additional long tip for instillation of normal to the extra-amniotic space. To the best of our knowledge, no comparison was performed between the use of the double balloon ripener device and folly catheter for induction of labor. Furthermore, there are no published data regarding the use of the double balloon instillation device (AID) combined with continuous extra-amniotic NS instillation. This study is designed to compare the efficacy, safety and side effects of mechanical methods of cervical ripening and labor induction by the double balloon device (ARD), the double balloon instillation device (AID) combined with continuous extra-amniotic instillation of normal saline and the folly catheter combined with continuous extra-amniotic normal saline instillation. The study aims at the accrual of 300 women (100 randomised in each arm).

02

Conditions studied

  • Unfavorable Cervix for Induction of Labor

Keywords

  • induction
  • cervix
  • balloon
  • Bishop
03

In context

Lead sponsor

Hillel Yaffe Medical Center is the lead sponsor of 305 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients 15 years of age or older.
  • Diagnosed to be pregnant with an indication for induction of labor.
  • Having a Bishop score of 4 points or less.
  • Diagnosed as having a singleton pregnancy in a vertex presentation, with intact membranes, and no significant regular uterine contraction at gestational age of >28 weeks.
  • Willingness to comply with the protocol for the duration of the study.
  • Have signed an informed consent.

Exclusion criteria

Exclusion Criteria:

  • Any contraindication for a vaginal delivery (i.e. placenta previa, non vertex presentation).
  • Ruptured membranes.
  • Previous cesarean section or any uterine scar.
  • Documented labor.
  • Suspected fetal distress necessitating immediate intervention.
  • Proven malignancy of the cervix.
  • Active inflammatory or purulent condition of the lower genital tract.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
300 participants (actual)

Study arms

  • Active comparator
    1

    Insertion of the Atad double balloon ripener device (100 ml NS in each balloon).

    Device: ARD (Atad Ripener Device)

  • Active comparator
    2

    Insertion of the double balloon instillation device (100 ml NS in each balloon) and continuous extra-amniotic instillation of NS 50 Ml/hour

    Device: AID (Atad double balloon Instillation Device)

  • Active comparator
    3

    Insertion of the folly catheter (40 ml NS in the balloon) and continuous extra-amniotic instillation of NS 50 Ml/hour

    Device: folly catheter

Interventions

  • DeviceARD (Atad Ripener Device)

    Atad double balloon ripener device

  • DeviceAID (Atad double balloon Instillation Device)

    Double balloon instillation device and continuous extra-amniotic instillation of NS 50 Ml/hour

  • Devicefolly catheter

    folly catheter (40 ml NS in the balloon) and continuous extra-amniotic instillation of NS 50 Ml/hour

06

What researchers measure

Primary outcomes

  1. To evaluate and compare the efficacy of the Atad Ripening Device (ARD), of the double balloon instillation device (AID) with concomitant continuous extra-amniotic NS instillation - 50 Ml/hour and of the folly catheter combined with continuous extra-a

    Time frame: 2 years

Secondary outcomes

  1. To assess the safety of the induction methods.

    Time frame: 2 years

  2. To assess the women's experience and satisfaction with the induction methods.

    Time frame: 2 years

  3. To compare the different cervical scoring systems available for predicting a successful induction.

    Time frame: 2 years

07

Study locations

1 site
  • Hillel Yaffe Medical Center
    Hadera, 38100, Israel
08

References and documents

Publications

  • de Vaan MD, Ten Eikelder ML, Jozwiak M, Palmer KR, Davies-Tuck M, Bloemenkamp KW, Mol BWJ, Boulvain M. Mechanical methods for induction of labour. Cochrane Database Syst Rev. 2023 Mar 30;3(3):CD001233. doi: 10.1002/14651858.CD001233.pub4. PubMed 36996264 ↗
  • Anabusi S, Mei-Dan E, Hallak M, Walfisch A. Mechanical labor induction in the obese population: a secondary analysis of a prospective randomized trial. Arch Gynecol Obstet. 2016 Jan;293(1):75-80. doi: 10.1007/s00404-015-3765-3. Epub 2015 Jun 9. PubMed 26054823 ↗
  • Walfisch A, Mei-Dan E, Hallak M. Trans-cervical double balloon catheter with and without extra-amniotic saline infusion for cervical ripening: a prospective quasi-randomized trial. J Matern Fetal Neonatal Med. 2015 May;28(7):848-53. doi: 10.3109/14767058.2014.935328. Epub 2014 Jul 11. PubMed 24939630 ↗
  • Mei-Dan E, Walfisch A, Valencia C, Hallak M. Making cervical ripening EASI: a prospective controlled comparison of single versus double balloon catheters. J Matern Fetal Neonatal Med. 2014 Nov;27(17):1765-70. doi: 10.3109/14767058.2013.879704. Epub 2014 Feb 3. PubMed 24397244 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 22, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00604487
Responsible party
elad mei-dan (Elad Mei-Dan, MD, Hillel Yaffe Medical Center) — Principal investigator
First posted
Jan 30, 2008
Start date
Jan 2008
Primary completion
Jan 2011
Completion
Jan 2011
Last update
Feb 22, 2016

Study contacts

Mordechai Hallak, M.D.
principal investigator · Department of Obstetrics & Gynecology, Hillel Yaffe Medical Center, Hadera

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion